Form 4: Matson Inc. Chairman and CEO Matthew Cox Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Matthew Cox, Chairman and CEO of Matson Inc., sold a total of 7,500 shares of common stock on July 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 31, 2024, Matthew J. Cox, Chairman and CEO of Matson, Inc. (MATX), sold 7,500 shares of the company's common stock.
- The sales were executed in multiple transactions at weighted average prices of $132.15, $133.06, and $134.03.
- These sales were conducted under a Rule 10b5-1 trading plan adopted on February 23, 2024.
- Following the reported transactions, Cox still beneficially owns 222,897 shares of Matson Inc. common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the stock sale was conducted under a pre-arranged 10b5-1 trading plan, indicating it was likely planned for personal financial management rather than reflecting a change in the executive's outlook on the company.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current inside information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.
Stakeholder Impact
- The stock sale may have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 07/31/2024 | Date of the stock sale transactions |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.